Skip to main content
menu toggle button
What we do
Main menu
Capabilities
Capabilities
Our Integrated Model
Commercialization
3PL and Importation
Regulatory services
Consulting services
Patient support programs
Clinics and nursing
Pharmacovigilance
Specialty Distribution
Pharmacy
Solutions
Solutions
Corporate Wellness programs
Digital Health Solutions
Innomar Pharmacy
Innomar Clinics
Who we are
Main menu
About us
Our leadership team
Corporate citizenship
INSIGHTS
NEWS & EVENTS
CAREERS
Find a clinic
Contact us
language picker toggle button
English
English
Français
search toggle button
Find a clinic
Contact us
INSIGHTS
NEWS & EVENTS
CAREERS
language picker toggle button
English
English
Français
Insights
Filter By
All Topics
Affordability
Analytics
Biosimilars
Commercialization
COVID-19
Data
Digital Solutions
Distribution
Legislation
Market access
Medical Device
Medication adherence
Medication therapy management
Oncology
Our role in healthcare
Patient care
Patient support services
Policy
Product access
Regulatory
Reimbursement
Research
Specialty pharmacy
Technology
Third-party logistics
Sort By
Date (Newest to Oldest)
Date (Oldest to Newest)
Title (A-Z)
Title (Z-A)
Filter
Innomar Strategies
Key insights from RAPS Convergence 2025
Innomar Strategies
November 2025
Navigating Canadian environmental regulations: A case study on NSNR compliance
Innomar Strategies
October 2025
What you need to know about renewing your Drug Establishment Licence (DEL)
Innomar Strategies
October 2025
Understanding XML Product Monographs
Innomar Strategies
May 2025
Case Study: Optimizing Procedures - Achieving Excellence in Medical Device Management
Innomar Strategies
May 2025
Pharmacovigilance: Canadian requirements
Innomar Strategies
April 2025
Webinar on-demand - A Panel Discussion on Navigating Medical Devices in Canada
Innomar Strategies
July 2024
Manufacturers
Drug development checklist: what to look for in a commercialization partner
Innomar Strategies
April 2024
Manufacturers
Pre-launch checklist: what to look for in a commercialization partner
Innomar Strategies
April 2024
Manufacturers
Post launch checklist: what to look for in a commercialization partner
Innomar Strategies
April 2024
Manufacturers
InnomarLive 2023: Part One
Innomar Strategies
April 2023
Manufacturers
InnomarLive 2023: Part Two
Innomar Strategies
April 2023
Manufacturers
InnomarLive 2023: Part Three
Innomar Strategies
April 2023
Manufacturers
Regulatory Services: Management and Control of Certified Product Information Document
Innomar Strategies
August 2022
Manufacturers
Webinar: Impact of COVID-19 on Patient Support Programs in Canada
Innomar Strategies
June 2021
Manufacturers
Case Study: Launching a new molecule for a rare disease
Innomar Strategies
April 2021
Manufacturers
Case Study: A proven approach for an emerging specialty pharma company
Innomar Strategies
April 2021
Manufacturers
Case Study: A flexible solution for launching a new molecule in oncology
Innomar Strategies
April 2021
Manufacturers
The value of Real-World Evidence in Canadian drug commercialization: Part 2
Innomar Strategies
April 2021
Manufacturers
Webinar: Utilizing Real World Evidence Across the Product Life Cycle
Innomar Strategies
June 2020
Manufacturers
Commercializing in Canada: Quality Assurance and GMP Services
Innomar Strategies
April 2020
Manufacturers
Commercializing in Canada: Regulatory Publishing and Submissions
Innomar Strategies
April 2020
Manufacturers
Webinar: Health Canada’s Regulatory and Quality approach to addressing COVID-19 challenges
Innomar Strategies
April 2020
Manufacturers
InnomarLive 2019: Commercializing in Canada
Innomar Strategies
December 2019
Explore More by Topic
Affordability
Analytics
Biosimilars
Commercialization
COVID-19
Data
brand="Cencora" culture="EN" env="Production" tracker="False"